Abbott Laboratories (ABT)

Price$87.78

Value ScoreC

Growth ScoreC

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-46.88%

Price vs S&P 500 (4W)-9.29%

VGM Score40.90

Market Capitalization$149.10B

P/E Ratio (Annual)22.85x

Indicated Dividend Yield (Annual)2.94%

All Metrics

P/CF (Annual)15.59x

Book Value / Share (Quarterly)$29.89

P/TBV (Annual)4.67x

Indicated Dividend (Annual)$2.52

Revenue Growth (3Y)0.51%

Cash Flow / Share (Quarterly)$4.24

Payout Ratio (TTM)66.73%

Price vs S&P 500 (YTD)-42.61%

Gross Margin (TTM)56.50%

Net Profit Margin (TTM)13.91%

EPS (TTM)$3.59

10-Day Avg Trading Volume11.55M

EPS Excl Extra (TTM)$3.59

Revenue Growth (5Y)5.08%

EPS (Annual)$3.73

Dividend / Share (Annual)$2.37

ROI (Annual)10.03%

Gross Margin (Annual)56.66%

Net Profit Margin (5Y Avg)18.65%

Cash / Share (Quarterly)$4.19

P/E Basic Excl Extra (TTM)23.76x

Revenue Growth QoQ (YoY)7.78%

EPS Growth (5Y)8.20%

P/E Normalized (Annual)22.85x

ROA (Last FY)7.52%

Revenue Growth TTM (YoY)6.59%

EBITD / Share (TTM)$5.38

ROE (5Y Avg)18.82%

Operating Margin (TTM)17.09%

Cash Flow / Share (Annual)$4.26

P/B Ratio2.86x

P/B Ratio (Quarterly)3.43x

Net Income / Employee (Annual)$56,700

EV / Revenue (TTM)3.91x

Net Interest Coverage (TTM)63.71x

ROA (TTM)6.87%

EPS Growth QoQ (YoY)-18.70%

EV / EBITDA (TTM)18.77x

EPS Incl Extra (Annual)$3.73

Current Ratio (Annual)1.58x

Quick Ratio (Quarterly)0.84x

3-Month Avg Trading Volume12.54M

52-Week Price Return-35.57%

EV / Free Cash Flow (Annual)23.85x

P/E Incl Extra (TTM)23.76x

Revenue / Employee (TTM)$392,500

Tangible BV / Share (Quarterly)$19.63

P/S Ratio (Annual)3.36x

Asset Turnover (Annual)0.51x

52-Week High$139.06

Operating Margin (5Y Avg)17.73%

EPS Excl Extra (Annual)$3.73

CapEx CAGR (5Y)-0.06%

Tangible BV CAGR (5Y)20.96%

26-Week Price Return-30.95%

Quick Ratio (Annual)1.02x

13-Week Price Return-26.37%

Total Debt / Equity (Annual)0.25x

Current Ratio (Quarterly)1.39x

Enterprise Value$176.34B

Revenue / Share Growth (5Y)5.53%

Asset Turnover (TTM)0.49x

Book Value / Share Growth (5Y)10.15%

Revenue / Employee (Annual)$385,500

Inventory Turnover (Annual)3.03x

Pretax Margin (Annual)19.10%

Cash / Share (Annual)$5.15

3-Month Return Std Dev25.11%

Gross Margin (5Y Avg)56.18%

Net Income / Employee (TTM)$54,600

EBITDA CAGR (5Y)5.07%

EBITDA Interim CAGR (5Y)-7.49%

ROE (Last FY)12.51%

Net Interest Coverage (Annual)55.98x

EPS Basic Excl Extra (Annual)$3.73

P/FCF (TTM)20.21x

Receivables Turnover (TTM)5.81x

EV / Free Cash Flow (TTM)23.90x

Total Debt / Equity (Quarterly)0.65x

EPS Incl Extra (TTM)$3.59

Receivables Turnover (Annual)5.97x

ROI (TTM)9.00%

Dividend Growth Rate (5Y)10.37%

P/S Ratio (TTM)3.30x

Pretax Margin (5Y Avg)18.10%

Revenue / Share (Annual)$25.36

Tangible BV / Share (Annual)$26.84

Forward P/E14.96x

Free OCF CAGR (5Y)5.26%

Price vs S&P 500 (52W)-63.77%

P/E Ratio (TTM)23.76x

EPS Growth TTM (YoY)-53.59%

Year-to-Date Return-31.68%

5-Day Price Return-2.07%

EPS Normalized (Annual)$3.73

ROA (5Y Avg)10.10%

Net Profit Margin (Annual)14.72%

Month-to-Date Return-5.72%

Cash Flow / Share (TTM)$4.80

EBITD / Share (Annual)$5.57

EPS Growth (3Y)-1.71%

Operating Margin (Annual)18.17%

LT Debt / Equity (Annual)0.19x

P/CF (TTM)15.75x

ROI (5Y Avg)13.71%

P/E Excl Extra (TTM)23.76x

LT Debt / Equity (Quarterly)0.57x

EPS Basic Excl Extra (TTM)$3.59

P/TBV (Quarterly)5.22x

Payout Ratio (Annual)63.09%

P/B Ratio (Annual)4.18x

Dividend / Share (TTM)$2.41

Inventory Turnover (TTM)2.88x

Pretax Margin (TTM)18.03%

Book Value / Share (Annual)$30.02

Price vs S&P 500 (13W)-36.12%

Net Margin Growth (5Y)2.53%

Dividend Yield (TTM)2.81%

Beta0.62x

P/FCF (Annual)20.16x

Revenue / Share (TTM)$25.84

ROE (TTM)12.20%

52-Week Low$81.97

vGradeC

gGradeC

mGradeD

vgmGradeC

Show chart for

Earnings Surprise History

Q1 261.15est. 1.16

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.00

4.03

4.00

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
ABTAbbott Laboratories	C	C	D	$87.78
LLYEli Lilly & Co.	D	B	B	$1082.20
JNJJohnson & Johnson	C	C	C	$223.51
ABBVABBVIE INC.	D	C	C	$212.93
MRKMerck & Co., Inc.	C	C	C	$115.17
NVSNovartis AG	C	C	C	$145.68
AZNAstraZeneca PLC	D	B	C	$179.71
NVONovo-Nordisk A/S	B	B	C	$44.07
PFEPfizer Inc.	B	C	C	$25.63
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$34.64
VRTXVertex Pharmaceuticals Inc	D	B	C	$438.40

About

Abbott is a diversified healthcare company with leading products in cardiovascular devices, diabetes care, diagnostics, and nutrition. The company manufactures pacemakers, defibrillators, continuous glucose monitors, diagnostic testing equipment, and infant nutritional products. Approximately 60% of sales come from international markets, providing significant geographic diversification.